Skip to main content
I.Ceram logo

I.Ceram — Investor Relations & Filings

Ticker · ALICR ISIN · FR0011511971 LEI · 969500R28RHD3HDEIL86 PA Manufacturing
Open in API
Filings indexed 157 across all filing types
Latest filing 2020-01-20 Report Publication Anno…
Country FR France
Listing PA ALICR

About I.Ceram

https://www.iceram.fr/

I.Ceram specializes in the design, manufacture, and marketing of orthopedic and reconstructive implants. The company's core technology is centered on porous alumina bioceramics, though it also utilizes metals and polymers. A key innovation is the development of active implants, such as its Ceramil line, which can be loaded with antibiotics like gentamicin. This feature enables the localized delivery of medication directly to bone tissue to prevent and treat infections post-surgery. The product portfolio includes implants for various joints and a bioceramic sternal implant designed for reconstructive procedures.

Recent filings

Filing Released Lang Actions
I.Ceram : Calendrier Financier 2020
Report Publication Announcement Classification · 1% confidence The document is titled "Calendrier financier 2020" (Financial Calendar 2020) and explicitly lists future dates for key financial events such as 'Chiffre d'affaires 2019' (2019 Revenue), 'Résultats annuels 2019' (2019 Annual Results), 'Assemblée Générale' (General Meeting), and 'Résultats semestriels 2020' (2020 Half-year results). This document is an announcement detailing the schedule for future report publications and meetings, rather than the reports themselves. Since it announces the schedule for various corporate events and financial releases, the most appropriate classification is Report Publication Announcement (RPA), as it informs investors about when reports will be released. It is not a specific report type (like 10-K or ER) but an announcement about them.
2020-01-20 French
I.Ceram : Bilan annuel du contrat de liquidité
Transaction in Own Shares Classification · 1% confidence The document is titled "Bilan du contrat de liquidité au 31 décembre 2019" (Liquidity Contract Balance Sheet as of December 31, 2019) and provides detailed transactional data (purchases and sales of shares) related to a liquidity contract managed by Gilbert Dupont for the company I.CERAM, covering the second half of 2019 (July to December) and referencing prior periods (June 28, 2019, and the start of 2019). This type of regular reporting on share transactions conducted under a liquidity agreement, often required by market regulators, details the company's own share activity. This aligns precisely with the definition of 'Transaction in Own Shares' (POS), which covers share repurchase/issuance activities, including those managed via liquidity contracts.
2020-01-03 French
I.Ceram : Réussite de la première implantation du sternum CERAMIL® au Canada
Regulatory Filings Classification · 1% confidence The document is titled as a press release ("Communiqué de presse") dated December 10, 2019, announcing a specific corporate event: the first successful implantation of their Ceramil® sternum in Canada under a special access program from Santé Canada. It details a medical/product milestone and includes boilerplate information about the company (I.CERAM) and investor contacts. This type of announcement, focusing on a significant operational or product development milestone rather than routine financial results (ER, IR) or mandatory regulatory filings (10-K, DEF 14A), fits best under the general category of Regulatory Filings (RNS) as a miscellaneous corporate announcement, or potentially a general Investor Relations communication. Given the options, RNS serves as the best fit for a press release announcing a significant, non-financial operational achievement and regulatory clearance milestone.
2019-12-10 French
I.Ceram : Participation au salon ACTIONARIA les 21 et 22 novembre 2019 à Paris
Regulatory Filings Classification · 1% confidence The document is a press release dated November 18, 2019, announcing the company I.CERAM's participation in the ACTIONARIA trade show on November 21-22, 2019. It details the company's plans to meet investors, discuss strategy, and mentions a presentation by the CEO. This type of announcement, which informs stakeholders about an upcoming event where the company will present its business or strategy to investors, aligns best with an Investor Presentation (IP) or a general announcement. Since it is an announcement about an event where presentations will occur, and it is not a formal regulatory filing like a 10-K or an earnings release, it fits the general scope of investor relations communication. However, none of the codes perfectly capture an 'Event Announcement' specifically. Given the context of meeting investors and discussing strategy, it is related to investor engagement. It is not a formal report (10-K, IR), a transcript (CT), or a management discussion (MDA). It is most closely related to investor communication materials. Since it is a specific announcement about an event rather than the presentation material itself, and it doesn't fit the other specific categories, the most appropriate general category for non-standard investor communications that aren't formal reports or earnings releases is Regulatory Filings (RNS) as a fallback, or potentially Investor Presentation (IP) if we interpret the announcement as promoting future investor engagement materials. Given the content is purely promotional/informational about an upcoming event, and not a formal report or a specific transaction notice, RNS is the safest fallback, but IP relates to investor focus. Since it is a press release announcing participation in an investor event, it is a form of investor relations communication. I will classify it as RNS as it is a general press release announcing an event, which is a common use case for RNS when other specific codes don't apply, although it has strong investor relations overtones.
2019-11-18 French
I.Ceram : Publication scientifique sur la 1ère implantation du sternum en céramique chez une enfant
Legal Proceedings Report Classification · 1% confidence The document is a press release or announcement detailing the publication of a scientific article in the *European Journal of Pediatric Surgery Reports* regarding a medical innovation (ceramic sternum implantation). It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a comprehensive interim report (IR). It is an announcement about external scientific validation and company news. Since it doesn't fit the specific categories like AGM-R, 10-K, ER, IR, or CT, and it is an announcement about company activity/news, the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous announcements that are not explicitly defined elsewhere, especially those related to general corporate news or publications not covered by other specific codes. Given the short length and the nature of announcing a publication, RNS is the best fit among the available options, although 'LTR' (Legal Proceedings Report) is clearly incorrect, and 'RPA' (Report Publication Announcement) usually refers to the publication of the company's own mandatory reports, not third-party scientific papers.
2019-10-21 French
I.Ceram : Résultats du 1er semestre 2019 - Forte croissance de l'activité Céramique (+64 %)
Earnings Release Classification · 1% confidence The document explicitly details the 'Résultats du 1er semestre 2019' (Results for the 1st half of 2019), including consolidated accounts (Chiffre d'affaires, Résultat d'exploitation, Résultat net) for H1 2019 compared to H1 2018. It mentions that the 'comptes semestriels' (half-yearly accounts) were approved by the board on September 3, 2019, and it is dated September 9, 2019. This structure—a summary of financial performance for a period shorter than a year, including key figures and management commentary—is characteristic of an Interim/Quarterly Report. Although it is a press release announcing the results, the content provided is the core financial summary, making 'Interim / Quarterly Report' (IR) the most appropriate classification over a simple 'Earnings Release' (ER) or 'Report Publication Announcement' (RPA), as it contains detailed financial tables and management discussion, not just highlights. The mention of the full report being available later (September 16) confirms this is the preliminary release/summary. H1 2019
2019-09-09 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.